Rankings
▼
Calendar
ACLX Q3 2023 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena
ACLX
Arcellx, Inc.
$7B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$15M
Gross Profit
$15M
97.0% margin
Operating Income
-$45M
-299.9% margin
Net Income
-$39M
-263.0% margin
EPS (Diluted)
$-0.81
QoQ Revenue Growth
+4.6%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$18M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$614M
Total Liabilities
$348M
Stockholders' Equity
$266M
Cash & Equivalents
$126M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$0
—
Gross Profit
$15M
$0
—
Operating Income
-$45M
-$94M
+52.2%
Net Income
-$39M
-$93M
+57.6%
← FY 2023
All Quarters
Q4 2023 →